Phase 1 Study assessing AB001 for Multiple Metastatic Solid Tumors
Latest Information Update: 10 Apr 2024
At a glance
- Drugs AB 001-Agastiya Biotech (Primary)
- Indications Advanced breast cancer; Ovarian cancer; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
Most Recent Events
- 10 Apr 2024 New trial record
- 03 Apr 2024 Results published in the Agastiya Biotech Media Release